Send feedback

SCRIB p.Leu158=

c.474C>T · rs56748182 · VCV3059254

Benign No assertion criteria
Classification
Benign
ClinVar
Review
No assertion criteria ☆☆☆☆
ClinVar · 1 submitter
gnomAD v4.1
Common
common (popmax 8.69%, nfe) — too common for a highly-penetrant pathogenic allele
Conditions
1
SCRIB-related disorder

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP -0.76GERP -3.3, phastCons 0.001
Overall
CADD4.472PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 8.69% European (non-Finnish) · 102,492/1,179,924 alleles
Filtering AF 8.64% ClinGen BA1/BS1 input FAF95, joint · FAF99 8.62%
Overall 7.81% 125,976/1,613,080 alleles · common exomes 116,134/1,460,796 · genomes 9,842/152,284 · joint denominator
Ancestry group Frequency 1 in
Amishnot grpmax-eligible 12.3% 8
Finnishnot grpmax-eligible 11.6% 9
European (non-Finnish)grpmax 8.69% 12
Remaining individualsnot grpmax-eligible 7.53% 13
Ashkenazi Jewishnot grpmax-eligible 6.07% 16
Middle Eastern 5.83% 17
South Asian 4.68% 21
Admixed American 4.09% 24
East Asian 2.15% 47
African / African-American 2.01% 50

Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
SCRIB
Protein
p.Leu158=
Coding
c.474C>T
MANE Select
NM_182706
dbSNP
rs56748182
Type
single nucleotide variant
Location
chr8:143813499 (GRCh38)
Gene constraint
LOEUF 0.684 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 52.33 · 42 PDB
Residue 158
the 'sufficient for targeting to adherens junction and to inhibit cell proliferation' region
Full SCRIB gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

SCRIB-related disorder

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/scrib-p-leu158 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown